ROLE OF MEDICINE (CITICOLINE) IN ADULT PATIENTS OF LAZY EYE (AMBLYOPIA)

EFFICACY OF ORAL CITICOLINE AS AN ADJUVANT THERAPY IN THE TREATMENT OF ADULT AMBLYOPIA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039809

Enrollment

Registered

2022-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H530- Amblyopia ex anopsia

Interventions

Intervention1: CITICOLINE ALONG WITH OCCLUSION THERAPY: 2 CYCLES OF 500 MG BD FOR 1.5 MONTHS EACH Intervention2: CITICOLINE ALONG WITH OCCLUSION THERAPY: 2 CYCLES OF 500 MG BD FOR 1.5 MONTHS EACH Inte

Eligibility

Inclusion criteria

Inclusion criteria: VISUAL ACUITY IN THE AMBLYOPIC EYE BETWEEN 6/60-6/12 VISUAL ACUITY IN THE SOUND EYE >6/12 AMBLYOPIA-STRABISMIC , ANISOMETROPIC OR BOTH NOT HAVING ANY OTHER OPHTHALMIC MORBIDITY

Exclusion criteria

Exclusion criteria: PATIENTS WITH MEDIA OPACITIES PATIENTS WITH PREVIOUS HISTORY OF ANY OCULAR SURGERY PATIENTS WITH HISTORY OF OCULAR TRAUMA PATIENTS HAVING ANY ALLERGY TO CITICOLINE

Design outcomes

Primary

Measure	Time frame
VISUAL ACUITY WILL BE ASSESSED AT 1 MONTH , 2 MONTHS , 3 MONTHS AND FINAL OUTCOME MEASURED AT 4 MONTHSTimepoint: 1 YEAR	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SUBHASH DADEYA

MAULANA AZAD MEDICAL COLLEGE AND ASSOCIATED GURU NANAK EYE CENTRE

dadeya868@gmail.com9810575899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026